MwanzoLUPIN • NSE
add
Lupin Ltd
Bei iliyotangulia
₹ 1,998.40
Bei za siku
₹ 1,999.00 - ₹ 2,059.55
Bei za mwaka
₹ 1,200.15 - ₹ 2,312.00
Thamani ya kampuni katika soko
988.81B INR
Wastani wa hisa zilizouzwa
elfu 927.92
Uwiano wa bei na mapato
35.74
Mgao wa faida
0.39%
Ubadilishanaji wa msingi
NSE
Habari za soko
.INX
0.56%
NVDA
2.15%
0.42%
3.69%
0.90%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 56.73B | 12.59% |
Matumizi ya uendeshaji wa biashara | 28.73B | 7.98% |
Mapato halisi | 8.53B | 74.12% |
Kiwango cha faida halisi | 15.03 | 54.63% |
Mapato kwa kila hisa | 18.64 | 73.88% |
EBITDA | 13.62B | 48.62% |
Asilimia ya kodi ya mapato | 18.52% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 29.12B | 68.06% |
Jumla ya mali | 254.82B | 8.69% |
Jumla ya dhima | 97.62B | -3.69% |
Jumla ya hisa | 157.20B | — |
hisa zilizosalia | 455.95M | — |
Uwiano wa bei na thamani | 5.83 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 15.22% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | 8.53B | 74.12% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1968
Makao Makuu
Tovuti
Wafanyakazi
19,210